Trial Profile
Effects of aspirin/dipyridamole [Aggrenox] and low-dose aspirin on platelet activity in patients after ischaemic stroke
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Aspirin/dipyridamole (Primary) ; Aspirin
- Indications Embolism and thrombosis; Stroke
- Focus Pharmacodynamics
- Acronyms AGATE
- 05 Nov 2010 New trial record.